robbins-llp-logo-white-background1583450-1.png
TWOU Class Action Alert: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the Class Action Against 2U, Inc.
27 juin 2024 15h44 HE | Robbins LLP
Robbins LLP is Investigating Allegations that 2U, Inc. (TWOU) Misled Investors Regarding it Business Prospects
Humana Inc. Class Action Lawsuit
HUM Class Action Alert: Robbins LLP Reminds HUM Stockholders About the Humana, Inc. Securities Fraud Class Action
20 juin 2024 13h30 HE | Robbins LLP
Robbins LLP is Investigating Allegations that Humana, Inc. (HUM) Misled Investors Regarding its Business Prospects
Marinus Pharmaceuticals, Inc. Class Action Lawsuit
MRNS Class Action Alert: Robbins LLP Reminds MRNS Stockholders About the Marinus Pharmaceuticals, Inc. Securities Fraud Class Action
20 juin 2024 13h30 HE | Robbins LLP
Robbins LLP is Investigating Allegations Marinus Pharmaceuticals, Inc. (MRNS) Misled Investors Regarding the Viability of its Drug Candidate
Intel Corporation Class Action
INTEL CORPORATION INVESTORS: Pending Lead Plaintiff Deadline in INTC Securities Fraud Class Action; Stockholders Should Contact Robbins LLP for Information
20 juin 2024 13h25 HE | Robbins LLP
Robbins LLP is Investigating the Allegations that Intel Corporation (INTC) Misrepresented its Business Prospects
Globe Life, Inc.  Class Action Lawsuit
GLOBE LIFE, INC. INVESTORS: Pending Lead Plaintiff Deadline in GL Securities Fraud Class Action; Stockholders Should Contact Robbins LLP for Information
20 juin 2024 13h19 HE | Robbins LLP
Robbins LLP is Investigating the Allegations that Globe Life, Inc. (GL) Engaged in Insurance Fraud
Altimmune, Inc. Class Action Lawsuit
ALTIMMUNE, INC. INVESTORS: Pending Lead Plaintiff Deadline in ALT Securities Fraud Class Action; Stockholders Should Contact Robbins LLP for Information
20 juin 2024 13h12 HE | Robbins LLP
Robbins LLP is Investigating the Allegations that Altimmune, Inc. (ALT) Misled Investors Regarding the Viability and Efficacy of its Weight Loss Drug
Robbins LLP logo white Background.png
Origin Materials, Inc. (ORGN) Shareholder Alert: Robbins LLP Reminds Shareholders of Class Action Filed Against Origin Materials, Inc.
31 août 2023 12h21 HE | Robbins LLP
SAN DIEGO, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of persons and entities that purchased or otherwise acquired Origin...
Robbins LLP logo white Background.png
MSP Recovery, Inc. (LIFW) Investor Alert: Robbins LLP Reminds Investors of Class Action Against MSP Recovery, Inc.
29 août 2023 18h43 HE | Robbins LLP
SAN DIEGO, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of persons or entities who: (1) purchased or otherwise acquired publicly...
Robbins LLP logo white Background.png
RTX Stock News: Investors with Significant Losses in RTX Corporation f/k/a Raytheon Technologies Corporation Should Contact Robbins LLP About Recovery
15 août 2023 14h33 HE | Robbins LLP
SAN DIEGO, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of persons who purchased or otherwise acquired publicly traded RTX...
Robbins LLP logo white Background.png
APLS Stock News: Investors with Significant Losses in Apellis Pharmaceuticals, Inc. Should Contact Robbins LLP About Recovery
14 août 2023 18h01 HE | Robbins LLP
SAN DIEGO, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action against Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) on behalf of persons or...